LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Capricor Therapeutics, Inc.

Similar companies to Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. Tech Stack

Capricor Therapeutics, Inc. uses 8 technology products and services including SAS, Dell, Exhibit, and more. Explore Capricor Therapeutics, Inc.'s tech stack below.

  • SAS
    Business Intelligence
  • Dell
    IT Infrastructure
  • Exhibit
    Javascript Graphics
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • HSTS
    Security
  • X-XSS-Protection
    Security
  • Apache HTTP Server
    Web Servers

Media & News

Capricor Therapeutics, Inc.'s Email Address Formats

Capricor Therapeutics, Inc. uses at least 1 format(s):
Capricor Therapeutics, Inc. Email FormatsExamplePercentage
FLast@capricor.comJDoe@capricor.com
50%
FLast@capricor.comJDoe@capricor.com
50%

Frequently Asked Questions

Where is Capricor Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Capricor Therapeutics, Inc.'s main headquarters is located at 10865 Road To The Cure Ste 150 San Diego, CA - California 92121 US. The company has employees across 4 continents, including North AmericaAsiaAfrica.

What is Capricor Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Capricor Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Capricor Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Capricor Therapeutics, Inc. is a publicly traded company; the company's stock symbol is CAPR.

What is Capricor Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Capricor Therapeutics, Inc.'s official website is capricor.com and has social profiles on LinkedIn.

How much revenue does Capricor Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of August 2024, Capricor Therapeutics, Inc.'s annual revenue reached $35M.

What is Capricor Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Capricor Therapeutics, Inc.'s SIC code is 8099 - Health and Allied Services, Not Elsewhere Classified NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Capricor Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2024, Capricor Therapeutics, Inc. has approximately 116 employees across 4 continents, including North AmericaAsiaAfrica. Key team members include Chief Executive Officer: L. M.Vice President Of Program Management, Business Operations And Quality: J. T.Vice President Of Rpd, Pd, Ad & Qc: M. S.. Explore Capricor Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Capricor Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Capricor Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Capricor Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Capricor Therapeutics, Inc.'s tech stack includes SASDellExhibitRSSOpen GraphHSTSX-XSS-ProtectionApache HTTP Server.

What is Capricor Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Capricor Therapeutics, Inc.'s email format typically follows the pattern of . Find more Capricor Therapeutics, Inc. email formats with LeadIQ.

How much funding has Capricor Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2024, Capricor Therapeutics, Inc. has raised $23M in funding. The last funding round occurred on Sep 29, 2023 for $23M.

When was Capricor Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Capricor Therapeutics, Inc. was founded in 2005.
Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc.

Biotechnology ResearchCA - California, United States51-200 Employees

Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives. Capricor is focused on the development of biologics, primarily cell and exosome-based technologies to treat or prevent a broad range of diseases. Our lead product is a cell therapy designed to treat Duchenne muscular dystrophy (DMD), the most severe form of muscular dystrophy, which results in muscle degeneration and premature death. Capricor’s innovative exosome technology is focusing on engineering exosomes to treat or prevent diseases with high unmet medical needs. Our translational approach to product development is based on the strong research foundation provided by our academic partnerships with leading scientists at top-tier research institutions.

Section iconCompany Overview

Headquarters
10865 Road To The Cure Ste 150 San Diego, CA - California 92121 US
Phone number
SIC Code
8099 - Health and Allied Services, Not Elsewhere Classified
Stock Symbol
CAPR
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
51-200

Section iconFunding & Financials

  • $23M

    Capricor Therapeutics, Inc. has raised a total of $23M of funding over 11 rounds. Their latest funding round was raised on Sep 29, 2023 in the amount of $23M.

  • $10M$50M

    Capricor Therapeutics, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $23M

    Capricor Therapeutics, Inc. has raised a total of $23M of funding over 11 rounds. Their latest funding round was raised on Sep 29, 2023 in the amount of $23M.

  • $10M$50M

    Capricor Therapeutics, Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.